Randomized Clinical Trial Comparing the Pharmacokinetics of Standard- and Increased-Dosage Lopinavir-Ritonavir Coformulation Tablets in HIV-Positive Pregnant Women

Antiretroviral Adherence During Pregnancy and Postpartum in Latin America

(2012) Regis Kreitchmann et al.   AIDS PATIENT CARE AND STDS

Thai HIV-1-infected women do not require a dose increase of lopinavir/ritonavir during the third trimester of pregnancy

(2011) Reshmie A Ramautarsing et al.   AIDS

Improved Oral Bioavailability of Lopinavir in Melt-Extruded Tablet Formulation Reduces Impact of Third Trimester on Lopinavir Plasma Concentrations

(2011) L. J. Else et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

CYP3A5, ABCB1, and SLCO1B1 Polymorphisms and Pharmacokinetics and Virologic Outcome of Lopinavir/Ritonavir in HIV-Infected Children

(2011) Natella Y Rakhmanina et al.   THERAPEUTIC DRUG MONITORING

Pharmacokinetics and virologic response of zidovudine/lopinavir/ritonavir initiated during the third trimester of pregnancy

(2010) Tim R Cressey et al.   AIDS

Therapeutic drug monitoring of lopinavir/ritonavir in pregnancy

(2010) JS Lambert et al.   HIV MEDICINE

Lopinavir Tablet Pharmacokinetics With an Increased Dose During Pregnancy

(2010) Brookie M Best et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Race, Ethnicity, Ancestry, and Pharmacogenetics

(2010) Thomas J. Urban   MOUNT SINAI JOURNAL OF MEDICINE

Antiretroviral Treatment in Pregnancy: A Six-Year Perspective on Recent Trends in Prescription Patterns, Viral Load Suppression, and Pregnancy Outcomes

(2009) Silvia Baroncelli et al.   AIDS PATIENT CARE AND STDS

An Evidence-Based Review of Treatment-Related Determinants of Patients' Nonadherence to HIV Medications

(2009) Mark J. Atkinson et al.   AIDS PATIENT CARE AND STDS

DNA tests probe the genomic ancestry of Brazilians

(2009) S.D.J. Pena et al.   BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH

Pharmacogenetics-Based Population Pharmacokinetic Analysis of Efavirenz in HIV-1-Infected Individuals

(2009) M Arab-Alameddine et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Factors influencing lopinavir and atazanavir plasma concentration

(2009) W. Stohr et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Pharmacokinetics of low-dose protease inhibitors and efavirenz in low- and middle-income countries

(2009) Meena Gorowara et al.   Current Opinion in HIV and AIDS

British HIV Association and Children's HIV Association guidelines for the management of HIV infection in pregnant women 2008

(2008) A de Ruiter et al.   HIV MEDICINE

Pharmacokinetics and short-term efficacy of a double-boosted protease inhibitor regimen in treatment-naive HIV-1-infected adults

(2008) J. van der Lugt et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Gender differences in the treatment of HIV infection

(2008) M FLORIDIA et al.   PHARMACOLOGICAL RESEARCH

Determination of lopinavir and ritonavir in blood plasma, seminal plasma, saliva and plasma ultra-filtrate by liquid chromatography/tandem mass spectrometry detection

(2008) Rita C. E. Estrela et al.   RAPID COMMUNICATIONS IN MASS SPECTROMETRY